Jiménez, N., de Herreros, M., Reig, O., Marin-Aguilera, M., Aversa, C., Ferrer-Mileo, L., . . . Mellado, B. (2024). Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Citación estilo ChicagoJiménez, N., et al. Development and Independent Validation of a Prognostic Gene Expression Signature Based On RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. 2024.
Cita MLAJiménez, N., et al. Development and Independent Validation of a Prognostic Gene Expression Signature Based On RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. 2024.
Precaución: Estas citas no son 100% exactas.